Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: ALS Treatment
Genetic Therapy Shows Promise for ALS and Dementia in Animal Models – Technology Networks
Posted: Published on February 20th, 2024
Macquarie University neuroscientists have developed a single-dose genetic medicine that has been proven to halt the progression of both motor neurone disease (MND) and frontotemporal dementia (FTD) in mice and may even offer the potential to reverse some of the effects of the fatal diseases. It may also hold opportunities for treating more common forms of dementia, such as Alzheimers disease, which is the second most common cause of death in Australia after heart disease. The new treatment, dubbed CTx1000, targets pathological build-ups of the protein TDP-43 in cells in the brain and spinal cord. Continue reading
Posted in ALS Treatment
Comments Off on Genetic Therapy Shows Promise for ALS and Dementia in Animal Models – Technology Networks
Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice – News-Medical.Net
Posted: Published on February 20th, 2024
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice and may even offer the potential to reverse some of the effects of the fatal diseases. It may also hold opportunities for treating more common forms of dementia, such as Alzheimer's disease. The new treatment, dubbed CTx1000, targets pathological build-ups of the protein TDP-43 in cells in the brain and spinal cord, which has been It has been associated with ALS, FTD and other forms of dementia Continue reading
Posted in ALS Treatment
Comments Off on Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice – News-Medical.Net
Significant Setback in ALS Treatment Development: What’s Next for Neurological Disease Treatments? – Medriva
Posted: Published on February 20th, 2024
A Significant Setback in ALS Treatment Development Denali Therapeutics and Sanofi, two notable names in the pharmaceutical industry, recently suffered a significant setback in their attempt to develop a promising treatment for Amyotrophic Lateral Sclerosis (ALS). The drug, which was in a mid-stage trial, did not meet its primary objective, casting a shadow over the future prospects of this potential treatment option. ALS is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and severe physical disability. Continue reading
Posted in ALS Treatment
Comments Off on Significant Setback in ALS Treatment Development: What’s Next for Neurological Disease Treatments? – Medriva
Amylyx to present ALS treatment developments at MDA conference By Investing.com – Investing.com
Posted: Published on February 20th, 2024
CAMBRIDGE, Mass. - Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has announced that it will present new research on two of its investigational treatments for amyotrophic lateral sclerosis (ALS) at the upcoming Muscular Dystrophy Association (MDA) Clinical and Scientific Conference in Orlando, Florida. Continue reading
Posted in ALS Treatment
Comments Off on Amylyx to present ALS treatment developments at MDA conference By Investing.com – Investing.com
Breakthrough in ALS Treatment: FP802 Inhibitor Shows Promise – Medriva
Posted: Published on February 12th, 2024
A Breakthrough in ALS Treatment Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by rapid, progressive loss of motor neurons in the brain and spinal cord. This debilitating condition, for which there is currently no cure, may soon see a ray of hope with the discovery of a new pharmacological inhibitor, FP802. Recent research funded by the German Research Foundation, the European Research Council, and the Alexander von Humboldt Foundation has unveiled the potential of this inhibitor in the treatment of ALS. Continue reading
Posted in ALS Treatment
Comments Off on Breakthrough in ALS Treatment: FP802 Inhibitor Shows Promise – Medriva
New drug targets key mechanism in ALS, protects motor neurons – News-Medical.Net
Posted: Published on February 12th, 2024
A new pharmacological inhibitor can intervene in a central cell death mechanism that is responsible for the death of motor neurons and hence important for the progression of the motor neuron disease amyotrophic lateral sclerosis (ALS). A research team led by Prof Continue reading
Posted in ALS Treatment
Comments Off on New drug targets key mechanism in ALS, protects motor neurons – News-Medical.Net
Heidelberg University’s Groundbreaking Discovery in ALS Treatment – Medriva
Posted: Published on February 12th, 2024
Groundbreaking Discovery by Heidelberg University In a major advancement towards the treatment of amyotrophic lateral sclerosis (ALS), a research team led by Prof. Dr. Continue reading
Posted in ALS Treatment
Comments Off on Heidelberg University’s Groundbreaking Discovery in ALS Treatment – Medriva
Revolutionary Discovery: FP802 Inhibitor Offers Hope for ALS Patients – Medriva
Posted: Published on February 12th, 2024
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrigs disease, is a progressive neurodegenerative condition marked by the loss of motor neurons, cells that control voluntary muscles. This fatal disease has been a longstanding challenge for researchers and physicians, with no effective cure available Continue reading
Posted in ALS Treatment
Comments Off on Revolutionary Discovery: FP802 Inhibitor Offers Hope for ALS Patients – Medriva